Correction to: PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/. BRCA1 DNA damage repair complex in prostate cancer cells
Crossref DOI link: https://doi.org/10.1186/s13046-022-02290-9
Published Online: 2022-02-22
Published Print: 2022-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yin, Linglong
Liu, Youhong
Peng, Yuchong
Peng, Yongbo
Yu, Xiaohui
Gao, Yingxue
Yuan, Bowen
Zhu, Qianling
Cao, Tuoyu
He, Leye
Gong, Zhicheng
Sun, Lunquan
Fan, Xuegong
Li, Xiong
Text and Data Mining valid from 2022-02-22
Version of Record valid from 2022-02-22
Article History
First Online: 22 February 2022